Revised SPCs: Mayzent (siponimod) film-coated tablets

Basal cell carcinoma is now listed as a potential adverse effect of treatment, with common frequency, and the warnings/precautions section on cutaneous neoplasms has been updated.

Source:

electronic Medicines compendium